FMII
ANIK icon

Farmers & Merchants Investments Inc’s Anika Therapeutics ANIK Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12
Closed -$312 – 1757
2023
Q2 		$312 Hold
12
– – ﹤0.01% 1674
2023
Q1 		$345 Buy
12
+3
+33% +$89 ﹤0.01% 1648
2022
Q4 		$266 Hold
9
– – ﹤0.01% 1715
2022
Q3 		$0 Buy
+9
New +$207 ﹤0.01% 1548

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Farmers & Merchants Investments Inc's ANIK Position: Q3 2023 in Review

Farmers & Merchants Investments Inc sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 12 shares — an estimated $312 sold.

Farmers & Merchants Investments Inc first reported a position in ANIK in Q3 2022 and held it in 4 quarters. The position peaked at $345 in Q1 2023. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • Farmers & Merchants Investments Inc reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 12 Anika Therapeutics shares in Q3 2023, an estimated $312.
  • Farmers & Merchants Investments Inc first reported a position in Anika Therapeutics in Q3 2022 and held it in 4 quarters.
  • Farmers & Merchants Investments Inc's Anika Therapeutics position peaked at $345 in Q1 2023.
  • 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2023, filed 25 Oct 2023.